Skip to content

AbbVie

NYSE: ABBV · USD

AbbVie cash flow and EPS95

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$3,401M
AbbVie capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2013 Q110.72% · $88M0% · $0M11.81% · $97M77.47% · $636MUnavailable100% · $821M
FY 2013 Q213.01% · $119M14.64% · $134M2.62% · $24M69.73% · $638MUnavailable100% · $915M
FY 2013 Q313.34% · $133M22.47% · $224MUnavailable64.19% · $640MUnavailable100% · $997M
FY 2013 Q414.52% · $151M4.52% · $47M19.33% · $201M61.63% · $641MUnavailable100% · $1,040M
FY 2014 Q112.38% · $137MUnavailable29.72% · $329M57.9% · $641MUnavailable100% · $1,107M
FY 2014 Q216.92% · $142MUnavailable2.86% · $24M80.21% · $673MUnavailable100% · $839M
FY 2014 Q312.78% · $180M39.42% · $555MUnavailable47.8% · $673MUnavailable100% · $1,408M
FY 2014 Q413% · $153M4.25% · $50M25.49% · $300M57.26% · $674MUnavailable100% · $1,177M
FY 2015 Q17.22% · $145M36.64% · $736M17.02% · $342M39.12% · $786MUnavailable100% · $2,009M
FY 2015 Q20.69% · $115M64.43% · $10,752M29.98% · $5,002M4.9% · $818MUnavailable100% · $16,687M
FY 2015 Q36.43% · $127M0% · $0M50.53% · $998M43.04% · $850MUnavailable100% · $1,975M
FY 2015 Q46.56% · $145M0% · $0M55.43% · $1,225M38.01% · $840MUnavailable100% · $2,210M
FY 2016 Q18.16% · $121M1.89% · $28M27.6% · $409M62.35% · $924MUnavailable100% · $1,482M
FY 2016 Q21.8% · $131M33.3% · $2,427M52.18% · $3,803M12.72% · $927MUnavailable100% · $7,288M
FY 2016 Q310.58% · $113M2.06% · $22MUnavailable87.36% · $933MUnavailable100% · $1,068M
FY 2016 Q43.95% · $114M0.62% · $18M63.14% · $1,824M32.29% · $933MUnavailable100% · $2,889M
FY 2017 Q14.71% · $95MUnavailable44.37% · $895M50.92% · $1,027MUnavailable100% · $2,017M
FY 2017 Q210.91% · $126MUnavailable0.43% · $5M88.66% · $1,024MUnavailable100% · $1,155M
FY 2017 Q310.89% · $126M0% · $0M0.43% · $5M88.68% · $1,026MUnavailable100% · $1,157M
FY 2017 Q410.6% · $182M0% · $0M29.41% · $505M59.99% · $1,030MUnavailable100% · $1,717M
FY 2018 Q14.43% · $119MUnavailable53.26% · $1,431M42.31% · $1,137MUnavailable100% · $2,687M
FY 2018 Q21.24% · $114MUnavailable82.04% · $7,516M16.71% · $1,531MUnavailable100% · $9,161M
FY 2018 Q310.25% · $282MUnavailable36.66% · $1,009M53.09% · $1,461MUnavailable100% · $2,752M
FY 2018 Q43.39% · $123MUnavailable56.66% · $2,058M39.95% · $1,451MUnavailable100% · $3,632M
FY 2019 Q14.62% · $107MUnavailable26.78% · $620M68.6% · $1,588MUnavailable100% · $2,315M
FY 2019 Q27.43% · $128MUnavailable0.17% · $3M92.4% · $1,592MUnavailable100% · $1,723M
FY 2019 Q38.81% · $154M0% · $0M0.23% · $4M90.97% · $1,591MUnavailable100% · $1,749M
FY 2019 Q49.26% · $163M0% · $0M0.11% · $2M90.63% · $1,595MUnavailable100% · $1,760M
FY 2020 Q14.94% · $125MUnavailable25.4% · $643M69.66% · $1,763MUnavailable100% · $2,531M
FY 2020 Q29.09% · $177MUnavailable0.98% · $19M89.94% · $1,752MUnavailable100% · $1,948M
FY 2020 Q39.29% · $217M0% · $0M0.86% · $20M89.86% · $2,100MUnavailable100% · $2,337M
FY 2020 Q49.97% · $279M4.36% · $122M10.58% · $296M75.09% · $2,101MUnavailable100% · $2,798M
FY 2021 Q15.7% · $188MUnavailable23.87% · $787M70.43% · $2,322MUnavailable100% · $3,297M
FY 2021 Q27.75% · $195MUnavailable0.4% · $10M91.85% · $2,310MUnavailable100% · $2,515M
FY 2021 Q38.55% · $217M0% · $0M0.24% · $6M91.21% · $2,315MUnavailable100% · $2,538M
FY 2021 Q45.92% · $187M16.63% · $525M4.15% · $131M73.3% · $2,314MUnavailable100% · $3,157M
FY 2022 Q13.9% · $162MUnavailable35.35% · $1,470M60.75% · $2,526MUnavailable100% · $4,158M
FY 2022 Q25.38% · $143MUnavailable0.34% · $9M94.28% · $2,507MUnavailable100% · $2,659M
FY 2022 Q36.59% · $177MUnavailable0.15% · $4M93.26% · $2,504MUnavailable100% · $2,685M
FY 2022 Q47.82% · $213MUnavailable0.15% · $4M92.03% · $2,506MUnavailable100% · $2,723M
FY 2023 Q13.65% · $175M0% · $0M40.81% · $1,955M55.54% · $2,661MUnavailable100% · $4,791M
FY 2023 Q26.33% · $178M0% · $0M0.36% · $10M93.32% · $2,625MUnavailable100% · $2,813M
FY 2023 Q37.68% · $219M0% · $0M0.14% · $4M92.18% · $2,627MUnavailable100% · $2,850M
FY 2023 Q47.23% · $205MUnavailable0.11% · $3M92.66% · $2,626MUnavailable100% · $2,834M
FY 2024 Q11.43% · $193M68.2% · $9,199M9.82% · $1,324M20.55% · $2,772MUnavailable100% · $13,488M
FY 2024 Q28.03% · $241M0% · $0M0.3% · $9M91.67% · $2,750MUnavailable100% · $3,000M
FY 2024 Q32.2% · $249M73.33% · $8,294M0.15% · $17M24.32% · $2,751MUnavailable100% · $11,311M
FY 2024 Q48.56% · $291M0% · $0M10.53% · $358M80.92% · $2,752MUnavailable100% · $3,401M
FY 2025 Q15.43% · $235M4.72% · $204M22.22% · $961M67.63% · $2,925MUnavailable100% · $4,325M
FY 2025 Q28.43% · $269M0% · $0M0.38% · $12M91.19% · $2,910MUnavailable100% · $3,191M
FY 2025 Q311.56% · $381M0% · $0M0.12% · $4M88.32% · $2,911MUnavailable100% · $3,296M
FY 2025 Q410.14% · $329M0% · $0M0.09% · $3M89.76% · $2,911MUnavailable100% · $3,243M
FY 2026 Q15.48% · $265M0% · $0M30.76% · $1,489M63.76% · $3,086MUnavailable100% · $4,840M
FY 2026 Q29.47% · $322M0% · $0M0.26% · $9M90.27% · $3,070MUnavailable100% · $3,401M
Mar 31, 2013 through Jun 30, 2026

Latest period omits debt repayments. Percentages cover tracked uses. SBC is noncash and excluded.

Operating cash flow

USD millions

$3,436M

Capital expenditures

USD millions

$322M

Free cash flow

USD millions

$3,114M

Stock-based compensation

USD millions

$166M

SBC / free cash flow

% · FCF before SBC deduction

5.33%

SBC / operating cash flow

%

4.83%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$2.03

Quarterly data

AbbVie cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20263,4363223,1141665.33%4.83%—$2.03
FY 2026 Q1Mar 31, 20263,8292653,56444412.46%11.6%—$0.39
FY 2025 Q4Dec 31, 20255,2183294,8891573.21%3.01%—$1.02
FY 2025 Q3Sep 30, 20257,0243816,6432093.15%2.98%—$0.1
FY 2025 Q2Jun 30, 20255,1532694,8841793.67%3.47%—$0.52
FY 2025 Q1Mar 31, 20251,6352351,40041029.29%25.08%—$0.72
FY 2024 Q4Dec 31, 20247,0482916,7571642.43%2.33%—$-0.02
FY 2024 Q3Sep 30, 20245,4472495,1981813.48%3.32%—$0.88
FY 2024 Q2Jun 30, 20242,2712412,03021810.74%9.6%—$0.77
FY 2024 Q1Mar 31, 20244,0401933,8473489.05%8.61%—$0.77
FY 2023 Q4Dec 31, 20234,7532054,5481252.75%2.63%—$0.46
FY 2023 Q3Sep 30, 20237,5742197,3551301.77%1.72%—$1
FY 2023 Q2Jun 30, 20236,3191786,1411792.91%2.83%—$1.14
FY 2023 Q1Mar 31, 20234,1931754,0183137.79%7.46%—$0.13
FY 2022 Q4Dec 31, 20227,4282137,2151321.83%1.78%—$1.38
FY 2022 Q3Sep 30, 20227,6021777,4251261.7%1.66%—$2.21
FY 2022 Q2Jun 30, 20225,0051434,8621072.2%2.14%—$0.51
FY 2022 Q1Mar 31, 20224,9081624,7463066.45%6.23%—$2.51
FY 2021 Q4Dec 31, 20215,0751874,8881292.64%2.54%—$2.26
FY 2021 Q3Sep 30, 20217,9352177,7181351.75%1.7%—$1.78
FY 2021 Q2Jun 30, 20214,8901954,6951593.39%3.25%—$0.42
FY 2021 Q1Mar 31, 20214,8771884,6892695.74%5.52%—$1.99
FY 2020 Q4Dec 31, 20204,8542794,5751362.97%2.8%—$0.01
FY 2020 Q3Sep 30, 20205,8302175,6131622.89%2.78%—$1.29
FY 2020 Q2Jun 30, 20203,0891772,9122368.1%7.64%—$-0.46
FY 2020 Q1Mar 31, 20203,8151253,6902195.93%5.74%—$2.02
FY 2019 Q4Dec 31, 20193,2751633,112792.54%2.41%—$1.88
FY 2019 Q3Sep 30, 20194,5551544,401751.7%1.65%—$1.26
FY 2019 Q2Jun 30, 20192,4771282,349873.7%3.51%—$0.49
FY 2019 Q1Mar 31, 20193,0171072,9101896.49%6.26%—$1.65
FY 2018 Q4Dec 31, 20183,3921233,269702.14%2.06%—$-1.23
FY 2018 Q3Sep 30, 20184,5242824,242751.77%1.66%—$1.81
FY 2018 Q2Jun 30, 20182,8661142,752853.09%2.97%—$1.26
FY 2018 Q1Mar 31, 20182,6451192,5261917.56%7.22%—$1.74
FY 2017 Q4Dec 31, 20172,5841822,402773.21%2.98%—$0.03
FY 2017 Q3Sep 30, 20173,2711263,145712.26%2.17%—$1.01
FY 2017 Q2Jun 30, 20172,0031261,877764.05%3.79%—$1.19
FY 2017 Q1Mar 31, 20172,102952,0071417.03%6.71%—$1.06
FY 2016 Q4Dec 31, 2016—114—75———$0.85
FY 2016 Q3Sep 30, 20161,4541131,341695.15%4.75%—$0.97
FY 2016 Q2Jun 30, 20161,9181311,787713.97%3.7%—$0.98
FY 2016 Q1Mar 31, 20162,1281212,0071386.88%6.48%—$0.83
FY 2015 Q4Dec 31, 20151,9631451,818532.92%2.7%—$0.92
FY 2015 Q3Sep 30, 20152,1551272,028552.71%2.55%—$0.74
FY 2015 Q2Jun 30, 20151,8321151,717553.2%3%—$0.83
FY 2015 Q1Mar 31, 20151,5851451,4401198.26%7.51%—$0.63
FY 2014 Q4Dec 31, 2014-578153-73143———$-0.51
FY 2014 Q3Sep 30, 20141,7861801,606442.74%2.46%—$0.31
FY 2014 Q2Jun 30, 20141,7171421,575483.05%2.8%—$0.68
FY 2014 Q1Mar 31, 201462413748710621.77%16.99%—$0.61
FY 2013 Q4Dec 31, 20131,2451511,094373.38%2.97%—$0.7
FY 2013 Q3Sep 30, 20131,7981331,665422.52%2.34%—$0.6
FY 2013 Q2Jun 30, 20132,0371191,918462.4%2.26%—$0.66
FY 2013 Q1Mar 31, 20131,187881,099877.92%7.33%—$0.6
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · ABBV, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.